231 related articles for article (PubMed ID: 19489038)
1. C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
Kim MH; Minton AZ; Agrawal V
Prostate; 2009 Sep; 69(13):1435-47. PubMed ID: 19489038
[TBL] [Abstract][Full Text] [Related]
2. Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
Kim MH; Fields J
Prostate; 2008 Sep; 68(12):1362-71. PubMed ID: 18512730
[TBL] [Abstract][Full Text] [Related]
3. C/EBPβ Mediates TNF-α-Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPK.
Xia P; Zhang R; Ge G
J Cell Biochem; 2015 Dec; 116(12):2766-77. PubMed ID: 25959126
[TBL] [Abstract][Full Text] [Related]
4. C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha.
Cappello C; Zwergal A; Kanclerski S; Haas SC; Kandemir JD; Huber R; Page S; Brand K
Cell Signal; 2009 Dec; 21(12):1918-24. PubMed ID: 19733238
[TBL] [Abstract][Full Text] [Related]
5. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells.
Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL
Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
[TBL] [Abstract][Full Text] [Related]
8. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
Dong G; Chen Z; Kato T; Van Waes C
Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
[TBL] [Abstract][Full Text] [Related]
9. C/EBP beta blocks p65 phosphorylation and thereby NF-kappa B-mediated transcription in TNF-tolerant cells.
Zwergal A; Quirling M; Saugel B; Huth KC; Sydlik C; Poli V; Neumeier D; Ziegler-Heitbrock HW; Brand K
J Immunol; 2006 Jul; 177(1):665-72. PubMed ID: 16785565
[TBL] [Abstract][Full Text] [Related]
10. Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes.
Ito Y; Daitoku H; Fukamizu A
Biochem Biophys Res Commun; 2009 Jan; 378(2):290-5. PubMed ID: 19026986
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells.
Lin CH; Nai PL; Bien MY; Yu CC; Chen BC
J Immunol; 2014 Jan; 192(1):338-48. PubMed ID: 24277696
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages.
Liu YW; Chen CC; Tseng HP; Chang WC
Cell Signal; 2006 Sep; 18(9):1492-500. PubMed ID: 16413748
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
16. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages.
Jana M; Dasgupta S; Saha RN; Liu X; Pahan K
J Neurochem; 2003 Jul; 86(2):519-28. PubMed ID: 12871593
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer.
Catz SD; Johnson JL
Oncogene; 2001 Nov; 20(50):7342-51. PubMed ID: 11704864
[TBL] [Abstract][Full Text] [Related]
20. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells.
Liu S; Shi X; Bauer I; Günther J; Seyfert HM
Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
